Wnt3a is a promising target in colorectal cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12032-023-01958-2.pdf
Reference136 articles.
1. Guirguis-Blake JM, Evans CV, Perdue LA, et al. Aspirin use to prevent cardiovascular disease and colorectal cancer: an evidence update for the US preventive services task force. JAMA. 2022. https://doi.org/10.1001/jama.2022.3337.
2. Rouhi L, Fan S, Cheedipudi SM, et al. The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure. Cardiovasc Res. 2022;118:1466–78.
3. Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:1–23.
4. Neiheisel A, Kaur M, Ma N, et al. Wnt pathway modulators in cancer therapeutics: an update on completed and ongoing clinical trials. Int J Cancer. 2022. https://doi.org/10.1002/ijc.33811.
5. Pawlikowski JS, McBryan T, van Tuyn J, et al. Wnt signaling potentiates nevogenesis. Proc Natl Acad Sci USA. 2013;110:16009–14.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Maintenance of stem cell self-renewal by sex chromosomal zinc-finger transcription factors;World Journal of Methodology;2024-12-20
2. The Interplay among Wnt/β-catenin Family Members in Colorectal Adenomas and Surrounding Tissues;Biomedicines;2024-08-02
3. Signaling pathways in colorectal cancer: implications for the target therapies;Molecular Biomedicine;2024-06-07
4. AI-Enhanced RAIN Protocol: A Systematic Approach to Optimize Drug Combinations for Rectal Neoplasm Treatment;2024-06-02
5. Targeting PI3K/AKT/mTOR signaling to overcome drug resistance in cancer;Chemico-Biological Interactions;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3